Company profile
NanoGhost
Harnessing the Homing Nature of Stem Cells in a Targeted Drug Delivery Platform
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Netanya, Israel
- Founded
- 2019
- LinkedIn followers
- 1,016
- Office locations
- 1
NanoGhost company summary
NanoGhost is a company in the Biotechnology Research industry, headquartered in Netanya, Israel, founded in 2019. On LinkedIn the company has around 12 employees and 1,016 followers. Its listed specialties include Nanotechnology, Oncology, Bio-convergence.
What technology does NanoGhost use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NanoGhost
NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites of inflammation. NanoGhost offers a novel, versatile, and highly selective targeted drug delivery platform for the treatment of oncological diseases. NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors (including brain tumors while crossing the BBB and pancreatic cancer), leading to a major reduction in tumor size and prolonged survival.
Specialties
Where is NanoGhost located?
NanoGhost lists 1 location.
Compare companies similar to NanoGhost
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NanoGhost nano-ghost.com | Biotechnology Research | 12 | 2019 | Netanya, Israel |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NanoGhost
What does NanoGhost do?
NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites of inflammation. NanoGhost offers a novel, versatile, and highly selective targeted drug delivery platform for the treatment of oncological diseases. NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors (including brain tumors while crossing the BBB and pancreatic cancer), leading to a major reduction in tumor size and prolonged survival.
How many employees does NanoGhost have?
NanoGhost has around 12 employees on LinkedIn.
Where is NanoGhost headquartered?
NanoGhost is headquartered in Netanya, Israel.
When was NanoGhost founded?
NanoGhost was founded in 2019.
Build a lead list from companies like NanoGhost
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.